Celaid Therapeutics is pleased to announce that it will participate in the Biotech Showcase, taking place from January 12 to 14, 2026, at the Hilton San Francisco Union Square, during JPM Week (*) in San Francisco, USA.
At this event, Nobuyuki Arakawa, President and CEO of Celaid Therapeutics, will participate and present the Company’s proprietary technology platform, pipeline, and mid- to long-term business strategy. In addition, he will engage in discussions regarding potential investment opportunities and possibilities for collaboration in research and development (R&D).
Those who are interested in partnering with, investing in, or conducting joint research with Celaid Therapeutics are encouraged to contact us.
Biotech Showcase 2026 – Event Overview
Dates: January 12–14, 2026
Venue: Hilton San Francisco Union Square (San Francisco, USA)
Official Website: https://informaconnect.com/biotech-showcase/
(*) JPM Week refers to the period surrounding the J.P. Morgan Healthcare Conference, held annually in January in San Francisco, during which leaders, investors, and companies from the biotechnology, pharmaceutical, and healthcare industries gather for networking and business development activities, including deal-making. During this time, key industry players convene for important meetings to drive partnerships and innovation, and numerous related events, such as BIO Partnering @ JPM Week, are also held.